226 related articles for article (PubMed ID: 16815863)
1. Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells.
Feist E; Brychcy M; Hausdorf G; Hoyer B; Egerer K; Dörner T; Kuckelkorn U; Burmester GR
Ann Rheum Dis; 2007 Jan; 66(1):5-11. PubMed ID: 16815863
[TBL] [Abstract][Full Text] [Related]
2. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the alpha and beta type.
Feist E; Kuckelkorn U; Dörner T; Dönitz H; Scheffler S; Hiepe F; Kloetzel PM; Burmester GR
Arthritis Rheum; 1999 Apr; 42(4):697-702. PubMed ID: 10211883
[TBL] [Abstract][Full Text] [Related]
4. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
Riemekasten G; Hiepe F
Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
[No Abstract] [Full Text] [Related]
5. Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 (beta1i), MECL1 (beta2i) and LMP7 (beta5i).
Scheffler S; Kuckelkorn U; Egerer K; Dörner T; Reiter K; Soza A; Burmester GR; Feist E
Rheumatology (Oxford); 2008 May; 47(5):622-6. PubMed ID: 18375405
[TBL] [Abstract][Full Text] [Related]
6. Anti-20S proteasome autoantibodies inhibit proteasome stimulation by proteasome activator PA28.
Brychcy M; Kuckelkorn U; Hausdorf G; Egerer K; Kloetzel PM; Burmester GR; Feist E
Arthritis Rheum; 2006 Jul; 54(7):2175-83. PubMed ID: 16802355
[TBL] [Abstract][Full Text] [Related]
7. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
Lee H; Kim Y; Han K; Oh EJ
Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
[TBL] [Abstract][Full Text] [Related]
8. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.
Tan EM
Adv Immunol; 1989; 44():93-151. PubMed ID: 2646863
[No Abstract] [Full Text] [Related]
9. Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease.
Ersvaer E; Bertelsen LT; Espenes LC; Bredholt T; Bøe SO; Iversen BM; Bruserud Ø; Ulvestad E; Gjertsen BT
Scand J Immunol; 2004; 60(1-2):189-98. PubMed ID: 15238089
[TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
Defendenti C; Atzeni F; Spina MF; Grosso S; Cereda A; Guercilena G; Bollani S; Saibeni S; Puttini PS
Autoimmun Rev; 2011 Jan; 10(3):150-4. PubMed ID: 20854935
[TBL] [Abstract][Full Text] [Related]
11. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
[TBL] [Abstract][Full Text] [Related]
12. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against Ku protein in sera from patients with autoimmune diseases.
Yaneva M; Arnett FC
Clin Exp Immunol; 1989 Jun; 76(3):366-72. PubMed ID: 2665976
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of autoantibodies to the pericentromeric heterochromatin protein 1a protein.
Coppo P; Henry-Dessailly I; Rochette J; Lok C; Buendia B; Lassoued K
Eur J Intern Med; 2013 Dec; 24(8):868-71. PubMed ID: 24184038
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune response to proteasome activator 28alpha in patients with connective tissue diseases.
Matsushita M; Takasaki Y; Takeuchi K; Yamada H; Matsudaira R; Hashimoto H
J Rheumatol; 2004 Feb; 31(2):252-9. PubMed ID: 14760793
[TBL] [Abstract][Full Text] [Related]
16. Testing for autoimmunity in humans.
D'Cruz D
Toxicol Lett; 2002 Feb; 127(1-3):93-100. PubMed ID: 12052646
[TBL] [Abstract][Full Text] [Related]
17. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
Jeong S; Yang D; Lee W; Kim GT; Kim HS; Ahn HS; Kim HJ
Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799
[TBL] [Abstract][Full Text] [Related]
19. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.
Lyons R; Narain S; Nichols C; Satoh M; Reeves WH
Ann N Y Acad Sci; 2005 Jun; 1050():217-28. PubMed ID: 16014537
[TBL] [Abstract][Full Text] [Related]
20. [Specific antibodies of soluble nuclear antigens in autoimmune vasculitis].
Weill BJ; Job-Deslandre C; Menkès CJ; Amor B
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):453-6. PubMed ID: 3303286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
